Free Trial

NKGen Biotech (NKGN) Insider Trading & Ownership

NKGen Biotech logo
$0.13 -0.01 (-8.62%)
As of 12:37 PM Eastern

NKGen Biotech (NYSE:NKGN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.36%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$1.26K
Number Of
Insiders Selling
(Last 3 Years)
0
Get NKGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling NKGen Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NKGN Insider Buying and Selling by Quarter

NKGen Biotech Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/6/2023Paul Y SongCEOBuy75$3.32$249.00  
11/27/2023Paul Y SongCEOBuy244$2.88$702.72  
11/21/2023Paul Y SongCEOBuy100$2.80$280.00  
11/20/2023James A GrafCFOBuy10$2.94$29.40  
(Data available from 1/1/2013 forward)

NKGN Insider Trading Activity - Frequently Asked Questions

The list of insiders at NKGen Biotech includes James A Graf, and Paul Y Song. Learn more on insiders at NKGN.

10.36% of NKGen Biotech stock is owned by insiders. Learn more on NKGN's insider holdings.

The following insiders have purchased NKGN shares in the last 24 months: James A Graf ($29.40), and Paul Y Song ($1,231.72).

Insiders have purchased a total of 429 NKGN shares in the last 24 months for a total of $1,261.12 bought.

NKGen Biotech Key Executives

  • Dr. Paul Y. Song M.D. (Age 58)
    CEO & Chairman
    Compensation: $36.58M
  • Mr. Sangwoo Park (Age 54)
    Executive Director
    Compensation: $576k
  • Mr. James A. Graf (Age 59)
    Interim CFO
  • Mr. Pierre Gagnon (Age 52)
    Chief Operating Officer
  • Ms. Yoonmi Kang
    Vice President of Technical Operations
  • Dr. Yong Man Kim Ph.D. (Age 59)
    Chief Scientific Officer
  • Ms. Denise A. Chua CLS
    MBA, MT (ASCP), Vice President of Investor Relations & Corporate Communications
  • Ms. Irene Chang
    Vice President of Human Resources
  • Mr. Ryan Park C.F.A.
    SVP of Financial Planning & Analysis and Corporate Strategy


This page (NYSE:NKGN) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners